Coronary Heart Disease Symptoms and Staying Heart-Healthy
Table of Contents Help Others Discover – Click to Share! Facebook Twitter LinkedIn Table of Contents Coronary heart disease (CHD) is the most prevalent form of heart disease and one of the leading causes of death in the world. Millions of individuals are diagnosed with CHD every year. CHD occurs when the coronary arteries, which provide the heart with oxygenated blood, become narrowed or blocked due to plaque build-up. Identifying the symptoms of CHD as early as possible can save lives, but many people can’t seek care due to busy work schedules or self-doubt about where to begin. This is why Cellmaflex can make a difference in your healthcare journey. With the ability to book appointments online, without ever needing to make a phone call, checking your entire medical history anytime, anywhere, and finding doctors, labs, imaging centres, and pharmacies in seconds, managing your heart health has never been easier. In this blog, we will define what is coronary heart disease, explore coronary heart disease symptoms, and identify major risk factors for the disease, diagnostic tests and prevention options, and discuss how Cellmaflex can help take control of your heart health proactively. What Is Coronary Heart Disease? Coronary heart disease (CHD), also known as ischemic heart disease, happens when the coronary arteries (blood vessels that carry oxygen-rich blood to the heart muscle) become narrowed or blocked with plaque. Plaque is a buildup of cholesterol, fat, calcium, and other substances that can be found in the inner lining of arteries, a process referred to as atherosclerosis. The buildup of plaque reduces blood flow, which restricts the heart’s access to the oxygen it requires to function properly. If left unchecked, CHD can lead to angina (chest pain), heart attacks, arrhythmias, or heart failure. In many cases, the first warning of CHD may be a heart attack, which is why it is important to monitor symptoms and risk factors for coronary heart disease. According to WHO, globally, coronary heart disease (CHD) caused approximately 9 million deaths in 2021, making it the single biggest killer worldwide. In 2022, an estimated 315 million people were living with CHD globally, including roughly 145 million men and 110 million women. WHO stated that cardiovascular diseases (CVDs), a broader category that includes CHD, caused an estimated 19.8 million deaths in 2022, representing about 32% of all global deaths. According to the Pan American Health Organization (PAHO), cardiovascular diseases (CVDs) remain the leading cause of death in the Americas, claiming over 2 million lives annually. In 2021, the age-standardized CVD mortality rates declined by 29.8% from 208.0 deaths per 100,000 population in 2000 to 146.1 deaths per 100,000 population in 2021. However, these rates vary significantly across countries, with Haiti having the highest rate at 427.7 deaths per 100,000 population. Country/Territory CVD Mortality Rate (per 100,000) Haiti 427.7 Dominican Republic 199.0 Jamaica 221.0 Trinidad and Tobago 193.0 Barbados 180.0 Saint Lucia 210.0 Saint Vincent and the Grenadines 215.0 Grenada 220.0 Saint Kitts and Nevis 230.0 Antigua and Barbuda 240.0 Taking care of your heart health is easier than ever with Cellmaflex. You can: – Find cardiologists and other specialists in your area – Book in-person or online appointments and diagnostic testing – Review your entire medical record to track your heart health trends – Coordinate care with labs, imaging, and pharmacies – Patients can do all these activities on their mobile devices in few taps! Coronary Heart Disease Symptoms Understanding the warning signs or coronary heart disease symptoms is important. Some patients have clear symptoms, while other patients are asymptomatic until a serious cardiac event arises. Here is a guide of what to look for: Chest Pain or Discomfort (Angina) Angina is the hallmark symptom of CHD. Patients often describe the sensation as pressure, squeezing, fullness, or tightness and may experience discomfort in the arms, shoulders, neck, jaw, or back. Usually, in the context of angina, the sensation rises with either an increase in physical activity or an increase in emotional stress when the heart requires more oxygen than the narrowed arteries can deliver. Shortness of Breath Reduced blood flow can impair the heart’s ability to pump efficiently, causing fluid buildup in the lungs and resulting in difficulty breathing, even during everyday activities Fatigue or Weakness If you are experiencing prolonged fatigue, it may be indicating that the heart is not receiving adequate oxygenated blood to ensure adequate bodily function. Heart Palpitations A heartbeat that is irregular or has an unusually fast rhythm can be a product of coronary arteries that may be unwell. Silent Symptoms Some individuals will have no symptoms at all until they experience a heart attack or sudden cardiac event: This is why a regime of routine monitoring and preventive health is crucial for this group of people. Key Risk Factors Some factors raise the chance of developing coronary heart disease. Understanding and managing the risks is important: High cholesterol levels and high blood pressure: Excess cholesterol can form plaques, narrowing arteries, while high blood pressure causes damage to arterial walls. Smoking and excessive alcohol: Both increase plaque formation and are detrimental to cardiovascular function Diabetes: High blood sugar damages blood vessels and increases the risk of CHD. Obesity and poor nutrition: Diets that are high in saturated fat, refined sugar, and processed foods contribute to plaque build-up. Physical Inactivity: A sedentary lifestyle weakens the heart and reduces circulation efficiency, increasing the risk of plaque buildup and coronary heart disease. Family history of heart disease: Genetics may contribute to the potential for developing CHD. With Cellmaflex, you will be empowered to address these risk factors. You can find dietitians, fitness professionals, and wellness clinics in your area, schedule follow-ups, and maintain records of key health indicators such as cholesterol, blood pressure, and blood sugar, all in one user-defined, user-friendly, simple-to-use digital health platform. Prevention and Management Engaging in preventive lifestyle practices and regular self-management can help prevent or manage coronary heart disease. Eat a Heart-Healthy Diet: Emphasise fruits, vegetables, whole grains, lean protein, and healthy fats while minimising processed foods and
The Role of CellmaEHR in Neonatal and Paediatrics: Safer and Smarter Care
Table of Contents Help Others Discover – Click to Share! Facebook Twitter LinkedIn Your browser does not support the audio tag. Table of Contents Newborn and child healthcare in the UK is facing increasing pressures. According to the Office for National Statistics (ONS, 2023), the neonatal mortality rate in England and Wales stands at 3.0 deaths per 1,000 live births, while infant mortality remains at 3.9 per 1,000 live births. Despite advancements in clinical practice, around 70% to 80% of all infant deaths occur during the neonatal period. Babies born before 24 weeks though fewer than 0.1% of births, accounted for 37.4% of neonatal deaths, with a mortality rate of 782.2 per 1,000 live births in this group. The National Child Mortality Database (2024) reported a child mortality rate of 29.8 deaths per 100,000 among children aged 0–17 years, underscoring persistent challenges in paediatric healthcare delivery. Hospital pressures also remain high, with over 829,000 emergency admissions of children under 18 recorded across the UK in 2023–24. These figures reflect the ongoing demand for efficient, integrated systems to manage neonatal and paediatric care, where accurate data, timely interventions, and cross-departmental communication are crucial for improving outcomes. Aligned with the NHS 10 Year Plan for virtual wards and neighbourhood care teams the CellmaEHR provides neonatal and paediatric care outside the four walls of a hospital. Cellma brings together maternal-baby records, NICU flowsheets, and outpatient paediatric workflows to create continuity of care across multiple care settings. The platform supports “structured” data capture for national datasets and reporting e.g., MSDS, Neonatal Data Set (NNRD), HES/SUS datasets, and helps to enable interoperability via the FHIR UK Core and SNOMED CT standards. For hospitals striving to provide fully integrated, safer care and meeting NHS aspirations, CellmaEHR in neonatal and paediatrics is not simply a clinical tool; it is a key partner in the delivery of care. Integrations and Standards Utilised by Cellma CellmaEHR has been developed to ensure that all aspects comply with UK healthcare standards, while integrating easily with existing hospital systems: National Standards & Terminologies: FHIR UK Core for interoperability, SNOMED CT for clinical terminology, LOINC for labs, ICD-10/OPCS for coding. NHS Spine / GP Connect: Enabling access to summary patient data, patient demographics and coordination of discharge. Electronic Prescription Service (EPS): Dosing workflows for child discharge prescriptions. Laboratory and Imaging Systems: Bidirectional integration with laboratory information systems (LIS), picture archiving and communication systems (PACS), radiology information systems (RIS) and any laboratory or imaging systems. Pharmacy and Blood Bank Systems: Drug reconciliations, neonatal drug library, medications tracked through infusion pumps, tracked by batches, or lots. Device and Bedside Integration: Receipt of real time device data from monitoring equipment, ventilators and infusion pumps using HL7 or FHIR streams. Public Health & Screening Services: Automatically capturing and reporting newborn bloodspot screening, hearing screening, and retinopathy of prematurity (ROP) screening. Data submissions & research: MSDS, Neonatal Data Set (NNRD), HES/SUS, & ONS reporting, including field-level validation. Security & privacy compliance: the GDPR, Data Security & Protection Toolkit (DSPT), & Caldicott principles and processes including role-based access, encryption, audit logs, & pseudonymisation for secondary research purpose. Parent and Care Coordination Portals: Regulated access to the records & assessments with consent to comply with the neonatal aspects. Through these specifications and integrations, CellmaEHR provides trustworthy, secure, and future-proof Electronic Health Records for neonates and paediatrics, supporting a single care ecosystem for modern hospitals and the NHS. Clinical Scope: Neonatal and Paediatric Care Population / Area Data & Features Neonates (delivery room, SCBU, NICU, transitional care) – Gestational & corrected age tracking, birth weight, APGAR scores, maternal linkage- Hourly/daily vitals, ventilator parameters, oxygen/CPAP settings, nutrition management (breastmilk, donor milk, parenteral nutrition)- Weight-based medication dosing with pump/infusion integration, transfusion tracking, lab results integration- Screening: bloodspot, hearing, congenital heart, ROP exams Paediatrics (children & young people, outpatient, ward, PICU) – Growth & development tracking (birth to 18 years), vaccination history, allergy documentation, PEWS scoring- Structured lab & imaging orders with SNOMED CT-coded problem lists- Safeguarding & social risk flags Challenges Addressed – Fragmented systems, data gaps, and alert fatigue- Resolved by Cellma EHR through maternal–baby linkage, device feeds, weight-based dosing alerts, and configurable clinical decision support tailored to neonatal and paediatric physiology Core Features of CellmaEHR Cellma’s platform can address the clinical, operational and compliance challenges within hospitals: Clinical Documentation and Flowsheets: Minute to minute neonatal flowsheets and paediatric ward templates with structured problem lists and configurable order sets. Drug Interaction: Weight and age-driven medication dosing engine, unique drug library for neonates, barcode medication administration (BCMA), and infusion pump interoperability. Order Entry & Results: Computerised Physician Order Entry (CPOE) that integrates with lab, imaging, and microbiology results. Device & Bedside Integration: Providing accurate documentation with live HL7/FHIR feeds from monitors, ventilators, and infusion pumps. Care Coordination: Involving maternal-baby links, discharge messaging to GPs/health visitors, and parental portals that can only be accessed through consent. Dashboards & Analytics: Including live NICU occupancy, tracking of ventilators, PEWS escalation for sick babies and planned extracts to send data to NNRD, HR-XML, HES/SUS, and MSDS. AI & NLP Intelligence in Cellma – Cellma uses AI and NLP to analyse clinical notes, detect risks early, and support accurate decision-making in neonatal and paediatric care. By linking all these modules together, Cellma alleviates burdensome administration, improves data quality for audits, and maximises staff attention on patients rather than paperwork. Security and compliance Cellma complies with all UK legal and NHS obligations, including GDPR compliance, DSP Toolkit compliance, and adopting the Caldicott principles. Sensitive neonatal and paediatric data are protected, with end-to-end encryption, role-based access control, audit record with logs, and multi-factor authentication. Cellma also uses pseudonymisation and secure extraction tools for safe secondary use of information for research and benchmarking. Why choosing Cellma is the right choice No matter if you are a NICU nurse or paediatric consultant, efficiency for staff and safety for patients is the most important aspect. CellmaEHR: Helps you spend less time calculating doses or retrieving historical records. Allows you to report accurately to national datasets. Easily integrates into virtual wards and neighbourhood care centres. Provides
Breast Cancer Symptoms, Diagnosis, and Treatment: What You Should Know
Table of Contents Help Others Discover – Click to Share! Facebook Twitter LinkedIn Table of Contents Hearing the words “you might have breast cancer” is one of the most overwhelming moments in a woman’s life. For many, it may start with noticing a small lump, a change in shape, or swelling, or a persistent pain that just feels “different.” The uncertainty, anxiety, and fear that follow can feel paralysing. Breast cancer not only affects the body but affects a woman’s emotional health, family life, daily routines, and way of life. With tools like Cellmaflex, managing health has become far more convenient. Women no longer need to wait endlessly on phone lines to book medical appointments. Instead, they can easily book an appointment online, access their medical record whenever they want, and search a doctor, pharmacy, lab, or imaging centre in their area in a matter of seconds. In this blog, we will cover everything you need to know about breast cancer, what is it, types, causes, breast cancer symptoms, complications, diagnosis, treatment, and how Cellmaflex helps promote better access to healthcare services and monitoring for patients. What Is Breast Cancer? Breast cancer occurs when abnormal breast cells begin growing uncontrollably, forming a tumour. These tumours may be benign (non-cancerous) or malignant (cancerous). Malignant tumours can invade surrounding tissues and may spread (metastasize) to other parts of the body if untreated. Recognising breast cancer symptoms early plays a pivotal role in stopping the disease from progressing. Cellmaflex plays a supportive role here by allowing women to keep a digital record of their medical history, imaging, and test results, making it easier for both patients and doctors to identify changes in breast health over time. According to the World Health Organization (WHO), breast cancer is the most common cancer among women worldwide. In 2022, there were an estimated 2.3 million women diagnosed with breast cancer and 670,000 deaths globally. Early detection saves lives, and while this is true for many women, many still wait to seek medical help until the symptoms of breast cancer have progressed. This often complicates treatment and worsens outcomes for women. Caribbean & Trinidad & Tobago Breast Cancer Statistics Statistic Detail Breast cancer is the leading cancer overall in Trinidad & Tobago Of 3,095 registered breast cancer cases in that period, it accounted for 17.6% of all cancers, and among women, it accounted for 33.1%. Incidence & mortality rates in T&T For women, the age-standardized incidence rate for breast cancer is 46.6 per 100,000; representing ~31.6% of female cancer cases. Survival rate in T&T The 5-year breast cancer survival rate is about 74.3%, with a recurrence-free survival rate of 56.4%. Trends in Jamaica In Jamaica, breast cancer made up more than one out of every three cancer diagnoses in women; ~1,208 new cases in 2020 (up from 974 in 2018). Mortality in Jamaica The death rate from breast cancer has increased from about 56.8 to 66.9 per 100,000 women over recent years. The case fatality (percentage of diagnosed women who die) ranges between 41% to 51%. Incidence & mortality across Caribbean countries • Haiti: incidence ~22/100,000; mortality ~11.5/100,000. • Bahamas: incidence ~98.9/100,000; mortality ~26.3/100,000. Age of peak incidence In most Caribbean countries, peak incidence of breast cancer is in the 65-69 age group, or sometimes later (70-74). Some countries have secondary peaks under age 60. Breast cancer types 1. Non-invasive (in situ) cancers The most common is ductal carcinoma in situ (DCIS), where there are abnormal cells in the lining of a breast duct, but it does not spread to the tissue nearby. DCIS is not life-threatening in the immediate sense, but it can lead to an increased risk of invasive breast cancer later. 2. Invasive cancers Invasive ductal carcinoma (IDC): The most common form of breast cancer. Starting in milk ducts then invading surrounding breast tissue. Invasive lobular carcinoma (ILC): Begins in lobules (glands that produce milk), often grows in a less defined pattern making it more difficult to identify. 3. Other types There are some rare but aggressive forms of breast cancer, such as inflammatory breast cancer – which causes red and inflamed tissue – and triple-negative breast cancer, which does not respond to hormonal therapies, which usually require chemotherapy. Causes & Risks Although there are multiple risk factors that increase the risk of breast cancer, the cause is often not clear. Age: More common among women aged over 50. Genetics: Hereditary mutations in genes such as BRCA1 and BRCA2 greatly increase susceptibility. Lifestyle factors: Obesity, sedentary lifestyle, alcohol consumption, and smoking. Hormonal influences: Early menstruation, late menopause, and long-term hormone replacement therapy. Cellmaflex can help women at higher risk by making it easier to schedule regular screenings, track family history, and access imaging or lab test results in one place. Breast Cancer Symptoms Recognising breast cancer symptoms early is essential. Signs include: A lump or thickening in the breast or underarm. Changes in breast size or shape. Skin changes such as dimpling, redness, or swelling. Nipple discharge (other than breast milk) or inversion. Persistent pain in one part of the breast. Should you observe any of the breast cancer symptoms it would be judicious to reach out to your healthcare provider promptly. Cellmaflex can help you with this process by allowing you to book your appointment online and find the closest imaging centre for your mammogram or ultrasound. Complications When breast cancer is untreated, it can cause significant complications, such as: Bone metastases – leading to fractures, pain, and restricted movement. (Metastases: are secondary tumors formed by the spread of cancer cells from a primary tumor to a distant part of the body through the bloodstream or lymph system.) Metastasis to the liver – jaundice (yellow eyes/skin), or abdominal swelling, and liver failure. Metastasis to the lung – chronic cough, shortness of breath, or chest pain. Brain metastases – causing headaches, seizures, changes in vision, or neurological deficits. Recognising breast cancer symptoms early and obtaining medical care as soon as possible is important for preventing the above complications. Diagnosis Early
CellmaEHR: Leading Oncology Clinical Management Software for Cancer Care
Table of Contents Help Others Discover – Click to Share! Facebook Twitter LinkedIn Your browser does not support the audio tag. Table of Contents Cancer prevalence has risen from nearly 3 million in 2020 to almost 3.5 million in 2025 and is expected to keep increasing. The demand for cancer care in the UK is at an unprecedented level. In 2025, there will be over 400,000 new cases for cancer, or roughly 1,100 people diagnosed per day. About 45.5% diagnosed in England (for those with known stage) are found at Stage 3 or 4. Breast, prostate, lung, and bowel cancers together account for over 50% of all new cancer cases. The NHS Long Term Plan aims to reach 75% of cancers diagnosed at early stage (1 or 2) by 2028. While survival rates do continue to rise, the sheer volume of cancer incidence and complexity of care pathways has markedly increased work engagement for oncology teams. From referrals, diagnostics, treatment planning, multidisciplinary meetings and survivorship care, administrative work demands have absorbed precious time that could be used more productively with patient care. This is where CellmaEHR steps in. Designed to reduce the oncology department administrative burden while aligning with all NHS integrations and standards. CellmaEHR, an oncology clinical management software aligns with NHS integrations, datasets, and the objectives of the NHS 10 Year Plan. Cellma reduces administrative burden while enabling better care coordination, neighbourhood-based support for early detection, and integration with modern models of care such as virtual wards. NHS Standards and Integrations Supported by Cellma Cellma adheres with and integrates fully with the complete suite of NHS datasets and guidelines for oncology-related data compliance and continuity of cancer pathways: Activity Datasets: Cancer Waiting Times (CWT), Hospital Episode Statistics (HES), Systemic Anti-Cancer Therapy (SACT), Radiotherapy Dataset (RTDS). Outcome Datasets: National Cancer Registration and Analysis Service (NCRAS), Office for National Statistics (ONS), National Cancer Audits, and Cancer Patient Experience Survey (CPES). Standards & Compliance: Fully compatible with NHS Spine services, GP systems, NHS App, Neighbourhood Care Records, and Virtual Ward Integration, while supporting HL7, FHIR, and CQC requirements for interoperability and data governance. Interoperability & Technical Standards: Cellma is HL7 v2/v3 message, FHIR APIs, DICOM for imaging, SNOMED CT terminology, ICD-10/11 coding, Read Codes and OPCS-4 procedure codes enabled, facilitating the consistent transfer and reporting of data across the complete oncology care pathway. By using these data sets, Cellma reduces duplication, allows for reporting to be automated, and allows oncology departments to demonstrate they are meeting national standards for performance with no additional administrative burden on the oncology department. Clinical Scope: The Management of Oncology Conditions with Cellma Oncology is not a condition, but a spectrum of cancers and associated issues. The most common cancers in the UK – breast, lung, prostate, and bowel, account for over half of all cases. Beyond these, oncology care must manage rare cancers, paediatric cancers, haematological malignancies, and acute oncology presentations such as neutropenic sepsis or spinal cord compression. Cellma facilitates the complete clinical process: Referral and Diagnosis: Oversees urgent GP referrals in the 2-week wait process, interacts with imaging and pathology systems, and helps automate the sharing of results. Multidisciplinary Team (MDT) Management: Provides structured MDT templates in which oncologists, radiologists, and surgeons can collaboratively document decisions in real time. Treatment Planning and Monitoring: Supports systemic anti-cancer therapy (chemotherapy, targeted therapy, immunotherapy), radiotherapy and surgical oncology. Acute Oncology Services: Records emergency admissions, and treatment complications, and ensures an expedient escalation. Follow-up & Survivorship: Generates automated end-of-treatment summaries, follow-up schedules, and survivorship care plans. Cellma digitises and coordinates these stages in a manner that maintains absolute clinical meaningfulness and reduces the complexity of the Oncology department’s administration associated with paper records, typing the same information in multiple systems, and broken communication. Key Features of Cellma EHR for Oncology Care Oncology departments face a unique set of administrative burdens: high referral volumes, complex treatment regimens, constant reporting to national datasets, and the coordination of MDTs. Cellma offers a solution to these issues in a clinically rich fully integrated platform: Electronic Patient Record (EPR): Gathers all oncology data (referrals, test results, imaging, treatment summaries) into a single locus of easily accessible information. This prevents redundancy and enables continuity of care across various providers. Patient Admission and Scheduling (PAS): Automates scheduling for diagnostics, consultations, and treatments, reducing appointment backlogs and cutting waiting times. Document Management: Digitises consent forms, MDT outcomes, and treatment plans, ensuring fast retrieval and compliance with NHS audits. Laboratory and Imaging Integrations: Integrates with pathology, radiology, and genomic testing platforms which are essential for accurate staging of cancer and personalised therapy. Pharmacy and Chemotherapy Management: Monitors all aspects of systemic anti-cancer therapy prescriptions for each patient, the dosage adjustment and side-effect management allowing minimising all medication errors and administration workload burden from therapy management. Theatre Management: Manages all aspects of surgical oncology scheduling and consumables so that cancer surgery is not delayed. Business Intelligence and Reporting: Provides automated CWT, SACT submissions, RTDS submissions, and NCRAS submissions all of which are useful to expedite manual reporting which causes delays in the Oncology Department Administration. Each module is designed to alleviate a particular pain point – whether it is delays in referral, data that has been missed by the MDT, or whether it is just the manual workload through reporting. With Cellma oncology teams spend less time on admin and more time on the patient-centred care. Security and Compliance in Oncology Care Oncology data is amongst some of the most sensitive patient health data in healthcare. To create confidentiality and trust for patients Cellma uses: Controls using role-based access and authorisation, preventing unauthorised access. End-to-end encryption of all data, in transit and at rest. Compliance with GDPR, NHS Digital standards and ISO certifications. Audit trails to provide accountability and transparency of all clinical and administrative actions. By implementing these, Cellma protects oncology data while reducing the risk of exposure to compliance breaches which only serve to increase the oncology department administrative burden. Oncology teams across the UK are facing high demand, increased complexity, and additional administrative requirements. Cellma EHR is a clinically robust
Understanding Cardiomyopathy Symptoms and Management
Table of Contents Help Others Discover – Click to Share! Facebook Twitter LinkedIn Your browser does not support the audio tag. Table of Contents Cardiomyopathy is one of the most significant heart conditions affecting people worldwide, often going unnoticed until it leads to serious complications. It weakens the heart muscle, disrupts blood circulation, and, if left untreated, can progress to heart failure or sudden cardiac arrest. Recognising early cardiomyopathy symptoms is vital for timely intervention and better outcomes. Living with a chronic heart condition can easily feel like you have a massive weight on your shoulders, but Cellmaflex makes it easier for patients to manage their own health. Patients can book appointments online without any phone calls, access their medical history from any location and find a doctor, pharmacy, lab and imaging close to them. The convenience of Cellmaflex is hugely supportive for patients with, or concerned about, cardiomyopathy, where prompt diagnosis and ongoing monitoring is key. In this blog, we will address the essential information regarding cardiomyopathy. What is cardiomyopathy, the types, causes, cardiomyopathy symptoms and risk factors, as well as diagnosis, complications and treatment. What is Cardiomyopathy? Cardiomyopathy encompasses a range of conditions that impair the heart muscle’s capacity to pump blood efficiently. Different from coronary artery disease or valve issues, cardiomyopathy makes the heart muscle weak or stiff. Cardiomyopathy can ultimately lead to heart failure, arrhythmias, or even sudden death. In 2019, there were approximately 3.73 million cases of obstructive cardiomyopathy (OC) and 0.71 million cases of atypical cardiomyopathy (AC) globally. In 2019, there were – 475,458 (range ~339,942–638,363) new cases of cardiomyopathy and myocarditis among older adults (aged 60-89). Global disability-adjusted life years (DALYs) in 2019 for CM-MC in older adults were – 3,372,716, according to National Library of Medicine. Types of Cardiomyopathy Cardiomyopathy isn’t a single disease but a category with several types: Dilated Cardiomyopathy (DCM): The most common form, which causes the heart’s chambers to enlarge and the heart’s ability to pump blood to weaken – often presenting with fatigue, breathlessness or swelling. Hypertrophic Cardiomyopathy (HCM): The heart muscle thickens, often in the left ventricle, making it harder for blood to leave the heart. This type is frequently inherited and can lead to fainting or even sudden cardiac death in young athletes. Restrictive Cardiomyopathy (RCM): The rarest type. The heart muscle becomes rigid and stiff, restricting filling between beats while the pumping ability remains normal or near normal. Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC): A rare inherited condition where healthy muscle in the right ventricle is replaced by fibrous or fatty tissue, causing dangerous arrhythmias. For patients diagnosed with any of the above types, keeping test results, prescriptions, and imaging scans organised is critical. Cellmaflex ensures that all of this information is consolidated into one secure spot and is readily available at anytime, anywhere. Causes & Risk Factors The causes of cardiomyopathy are diverse and sometimes unknown. Common factors include: Genetic mutations that run in families Previously inflicted damage to the heart, such as prior heart attack or coronary artery disease Long-term high blood pressure, which forces the heart to work harder Metabolic disorders such as diabetes or thyroid dysfunction Lifestyle that includes an excessive amount of alcohol, drug abuse, or poor diet Infections, particularly viral myocarditis, that kills heart muscle cells. People with these risk factors can benefit greatly with early screening. With Cellmaflex patients can book routine check-ups, receive timely lab referrals, and reminders for follow-ups. Cardiomyopathy Symptoms Cardiomyopathy symptoms can be hard to identify since they can vary significantly from patient to patient. Some patients show no symptoms in early stages, while others may experience sudden severe complications. The most common signs and symptoms include: Shortness of breath with physical activity, or at rest Fatigue, decreased endurance, or just a general feeling of being weak Swelling of the legs, ankles or feet (edema) Irregular heartbeat, racing heart, or strong “thudding” heartbeats Light-headedness, dizziness, or fainting Chest discomfort, especially with exertion. Complications of Cardiomyopathy Cardiomyopathy can lead to major complications if not recognised and managed: Heart failure: The heart can no longer deliver sufficient blood flow for the body’s needs. Arrhythmias: Abnormal heartbeats that result in fainting, and possibly sudden cardiac death in serious cases. Blood clots: Reduced blood flow can enable clots to develop in the heart, which can migrate to the brain and induce stroke. Valve problems: An enlarged heart can put too much stress on the valves which can lead to them becoming stretched and not working normally and develop leakage in the valves that can, eventually, worsen heart function. Diagnosis An accurate diagnosis requires a full assessment that combines medical history with laboratory tests, as follows: Physical exam: Your doctor will evaluate you for swelling, murmurs and irregular rhythms. Electrocardiogram (ECG/EKG): To assess for abnormal electrical heart activity. Echocardiogram: To assess the size, thickness, and ability of the heart to pump. Imaging via a cardiac MRI and/or CT scans. Blood tests to assess for thyroid disorders, infection and/or iron overload. Genetic testing to detect suspected hereditary forms of the disease. For patients juggling multiple tests across different facilities, Cellmaflex eliminates confusion by allowing them to upload and share results digitally with any clinician they visit. Treatment and Management There is no one treatment for cardiomyopathy, but treatment that focuses on controlling cardiomyopathy symptoms, slowing disease progression, and preventing complications. The options include: Lifestyle changes – Adopting heart-healthy habits plays a vital role in managing cardiomyopathy and supporting overall cardiovascular health. This includes: Following a balanced diet rich in fruits, vegetables, whole grains, lean proteins, and low-fat dairy while reducing salt, sugar, and saturated fats to maintain healthy blood pressure and cholesterol levels. Maintaining a healthy weight, as excess weight puts additional strain on the heart and can worsen symptoms. Engaging in regular, moderate physical activity such as walking, swimming, or cycling, tailored to the patient’s tolerance and doctor’s guidance. Limiting or avoiding alcohol consumption, since alcohol can weaken heart muscle and aggravate cardiomyopathy. Quitting smoking, which improves circulation, lowers blood pressure,
Streamlining General Surgery with Cellma: From Admin Relief to Better Outcomes
Table of Contents Help Others Discover – Click to Share! Facebook Twitter LinkedIn Your browser does not support the audio tag. Table of Contents General surgery is one of the most active specialties in the NHS with over 1.8 million inpatient episodes and over 1.35 million procedures annually according to GIRFT – General Surgery. As of April 2025, only 59.7% of patients in England began consultant-led treatment within the NHS’s 18-week referral-to-treatment target, far below the 92% standard. By January 2025, there were still 198,868 patients waiting more than 52 weeks for treatment, and nearly 14,975 patients waiting over 65 weeks, though this did mark an improvement compared to 2024, with a 38% reduction in year-long waits and an 85% reduction in waits over 78 weeks. Despite the commitment of general surgery departments across the UK, they continue to face significant challenges: increasing patient numbers, reduced exposure to training, variance in trauma work, and the subsequent impact of COVID-19. These challenges have subsequently required, in some cases, increased hours spent on administrative work, which ultimately means practitioner time with patients is reduced. Cellma EHR represents a great solution for this. Cellma improves general surgery workflows, thus reducing administrative burden, helps in complying with NHS procedures, and helps with safer and effective patient care. NHS Standards and Integrations within Cellma Cellma is designed to align with NHS frameworks, digital standards, and datasets, ensuring general surgery workflows are both clinically robust and compliant. Some of the key integrations include: GP Connect – Instant access to GP records for safer perioperative care. Shared Care Records – continuity of care across acute, community, and primary settings. Care Identity Service 2 (CIS2) – Secure authentication for NHS staff. • Personal Demographics Service (PDS) – accurate patient identification at every step. FHIR Interoperability – Seamless communication across hospital systems. Hospital Episode Statistics (HES) – Including APC, Critical Care, Outpatient, and A&E datasets. Diagnostic Imaging Dataset (DID) – Direct integration of radiology into the surgical record. Surgical Devices and Implants Core Dataset – National reporting on device use. Critical Care Minimum Dataset (CCMDS) – Structured postoperative and ICU data. With these integrations, Cellma does more than digitise notes, it ensures surgery teams remain fully aligned with NHS data requirements while streamlining general surgery pathways. Scenarios in General Surgery and Cellma’s Support Scenario in General Surgery Cellma’s Support Emergency Surgery (appendicitis, bowel obstruction, perforated ulcer) Pre-filled clerking templates, integrated labs & imaging, digital consent linked to live emergency theatre lists Elective Surgery (hernia repair, cholecystectomy, colorectal resections) NHS e-Referral integration, pre-assessment clinic workflows, waiting list prioritisation, checklist automation Trauma Surgery (splenic rupture, blunt abdominal trauma) ATLS-based trauma templates, direct imaging integration (FAST, CT), structured documentation for operative/non-operative cases Oncological Surgery (colorectal, gastric resections) MDT documentation, pathology & imaging integration, longitudinal tracking with scheduled follow-ups Post-Operative & Critical Care Live ward lists with NEWS2 scoring, CCMDS-linked ICU data, alerts for abnormal results, e-Pharmacy for safe prescribing Discharge & Follow-up Auto-generated discharge summaries, instant secure GP transfer via PDS, follow-up scheduling Auditing & Reporting Automated reports aligned with HES, DID, CCMDS, and Surgical Devices datasets, reducing audit prep time By offering end-to-end digital pathways, Cellma ensures consistency in surgical documentation and patient care, a true example of streamlining general surgery. Key Features of Cellma for General Surgery Care Management Surgical teams can spend more time on admin than any patient-facing care. Cellma offers a solution to this obvious imbalance with a suite of specialty-specific modules: Electronic Patient Record (EPR): Standard templates for clerking, operative notes, post-op reviews, and discharge summaries that auto-populate clinical details. Patient Administration System (PAS): Full digital approach to referral management, live theatre scheduling, and bed management for elective and emergency pathways. Imaging Integrations: Radiology results (DID-linked) flow directly into EPR – no more following up reports across systems. Laboratory Management: Blood results automatically flagged for any abnormality and shown as trends for perioperative optimisation. E-Pharmacy: Fully integrated e-prescribing for perioperative prescribing, antibiotic stewardship, and discharge medications. Theatre module: Digital consents linked directly to theatre lists to ensure safe coordination without misplaced documents. Document Management: Operation notes, consent forms, MDT outcomes, and checklists all securely stored and instantly recalled. BI & Analytics: Automated reports that line up with NHS datasets (HES, CCMDS, DID) to ease burden of audit and preparation for governance meetings. Addressing the Challenges in General Surgery Emergency workload & reduced training opportunity: Cellma reduces clerking duplication, and gives structured digital notes, so trainees spend more time in theatres. Variability in the volume of trauma: Centralised trauma documentation means we will be able to record learning cases for educational logs. In this way, Cellma is streamlining general surgery, increasing the efficiency of workflow, patient safety, and patient care. Security of Cellma GDPR compliant data processing Role-based access controls to protect patient confidentiality Audit trails of every entry ISO 27001. Cyber Essentials Plus. NHS DSP Toolkit compliant. Surgeons and administrators can trust that patient data is safe, even as it flows across different care settings. The demand on general surgery departments is ever rising, making it crucial to simplify general surgery workflows. By having integrations with NHS datasets, specialty specific modules, and a secure infrastructure, Cellma EHR alleviates some of the administrative pressures and supports the whole surgical pathway – referral, treatment, post-operative, and discharge. Want to find out how Cellma can support your surgical team? Get in touch to book a free demo today and discover how we’re simplifying general surgery for better results. Book a Free Demo Recent Blogs Let’s transform healthcare together. Speak with RioMed for a tailored solution. Get in Touch FAQs
Arrhythmia Symptoms: A Complete Guide to Causes, Risks, and Treatments
Table of Contents Help Others Discover – Click to Share! Facebook Twitter LinkedIn Your browser does not support the audio tag. Table of Contents When your heart skips a beat, flutters unexpectedly, or starts pounding out of rhythm, it can be a frightening experience. These sensations may point toward a condition called arrhythmia, a disorder of the heart’s rhythm that affects millions of people worldwide. For patients, one of the most important steps is timely medical care, and this is where digital solutions like Cellmaflex play a crucial role. With Cellmaflex, you can book online appointments without waiting on phone calls, check your medical history anytime and anywhere, and even find doctors, pharmacies, labs, and imaging services nearby. This ease of access ensures you can respond quickly to worrying heart symptoms. In this blog, we’ll take an in-depth look at arrhythmia, what it is, the different types, causes, symptoms, complications, diagnosis methods, treatments, and how to live with the condition. Along the way, we’ll also highlight how Cellmaflex helps make healthcare management more convenient and connected. What Is Arrhythmia? Normally, your heart beats in an organised, coordinated way. Issues with various parts of your heart – or even the blood your heart pumps – can affect your heart’s normal rhythm. Having a normal heart rhythm matters because your heart supplies your whole body with nutrients and oxygen through the blood it pumps. In a healthy adult, this typically means 60–100 beats per minute at rest. Arrhythmia occurs when these impulses misfire, causing the heart to beat too fast (tachycardia), too slow (bradycardia), or irregularly. Not all arrhythmias are immediately dangerous, but some can cause serious complications if untreated. According to Science Direct, in 2021, Atrial Fibrillation/Atrial Flutter (AF/AFL) was the most common arrhythmia globally, affecting 52.55 million people and causing over 338,000 deaths. Additionally, according to European Society of Cardiology, 1 in 3 people worldwide will develop a potentially life-threatening heart rhythm disorder in their lifetime, yet awareness remains critically low. In the Caribbean: Country Estimated Arrhythmia / AF Prevalence (%) Trinidad & Tobago ~5.3% (in stroke inpatients) Dominican Republic ~8–9% (in people >65 years) Given these high numbers, awareness of arrhythmia and its symptoms is more important than ever, and with Cellmaflex, patients can stay ahead by booking preventive health check-ups and monitoring their medical records conveniently. Types of Arrhythmias Not all arrhythmias are the same. Some are harmless, while others can be life-threatening. Atrial Fibrillation (AFib): The most common arrhythmia. In AFib, the upper chambers (atria) beat rapidly and irregularly, increasing the risk of stroke. Many patients don’t notice it until complications occur. Bradycardia: A slower-than-normal heart rate, which can cause fatigue, dizziness, or fainting spells. In severe cases, it may require a pacemaker. Tachycardia: A faster-than-normal heartbeat. While moments of tachycardia can happen as a response to stress or exercise, sustained or frequent tachycardia should be assessed by a medical professional. Ventricular Arrhythmias: These arrhythmias are not only dangerous but originate in the ventricles of the heart. With dangerous consequences, if not treated immediately, can lead to immediate cardiac arrest. Causes & Risk Factors Arrhythmias do not often just arise without reason. The most common causes and risk factors include: Cardiovascular Conditions: Heart disease, prior heart attack or valve disorder High Blood Pressure: a notable contributor to AFib and other rhythm problems Thyroid Condition: both overactive and underactive thyroid glands can cause arrhythmias Lifestyle Triggers: too much caffeine, alcohol, smoking or recreational drugs. Family History: genetic propensity to rhythm disorders. Medication and Electrolyte Imbalance: some drug use and low potassium, magnesium or calcium levels. If you have these risk factors, staying proactive is key. Through Cellmaflex, you can book blood tests, thyroid checks, and cardiology referrals quickly and access results in real time, helping you and your doctor act before symptoms worsen. Arrhythmia Symptoms Recognising arrhythmia symptoms can be lifesaving. Common warning signs include: A sensation of fluttering, pounding, or irregular heartbeat (palpitations) Dizziness, light-headedness, or fainting Shortness of breath during routine activities Unexplained fatigue or weakness Chest pain or pressure However, not all arrhythmias show clear signs. In fact, some people live with silent arrhythmias without knowing it. This makes regular screening vital, especially if you have risk factors. With Cellmaflex, you can schedule ECGs, keep past results handy, and share them with healthcare providers instantly, giving doctors a clear view of your heart history. By paying attention to arrhythmia symptoms early and using tools like Cellmaflex for convenient care, patients can prevent complications before they escalate. Working Through the Complications Untreated arrhythmias (some) can develop into serious and, at times, fatal conditions: Stroke: In patients with Atrial Fibrillation (AFib), stroke risk increases because the irregular heartbeats can cause blood to pool and develop a clot in the heart chambers (atria). Heart failure: Long-standing arrhythmias can weaken the heart muscle, making the heart ineffective in pumping blood. Sudden cardiac arrest: Severe ventricular arrhythmia can cause the heart to stop beating in its entirety! Working Through the Diagnosis Arrhythmias are often not diagnosed in one visit and depending on the frequency of the symptoms, monitoring over time may be necessary to diagnose an arrhythmia the common tools for arrhythmia diagnosis would be: Electrocardiogram (ECG/EKG): This is a test that records the electrical activity of the heart and captures varying rhythms. Holter Monitor: This is a kind of ECG monitor that is worn typically for 24 to 48 hours to take a record of irregular heartbeats that an ECG may miss. Event Monitor: Used for weeks at a time, activated by the patient during symptoms. Blood Tests: Check thyroid function, anaemia, or electrolyte imbalances that may contribute to arrhythmia. Cellmaflex provides support so that patients can book their diagnostic tests online and see the results electronically; therefore, they are always ready for their follow-up consultations. Treatment & Management Treatment is determined by the type of arrhythmia, the severity of any underlying disease, and the patient’s health. Treatments include: Lifestyle Modifications: Heart-healthy diet, regular physical activity; manage weight; moderate
Why CellmaEHR is the Emergency Department EHR You Need
Table of Contents Help Others Discover – Click to Share! Facebook Twitter LinkedIn Table of Contents Urgent and emergency care in England is under immense pressure. In March 2025 alone, 2,389,064 patients attended A&E, with an average of 77,067 daily attendances, a 3.6% rise from February. Yet only 75% of patients were admitted, transferred, or discharged within four hours, well below the NHS constitutional standard of 95%. Ambulance response times, overcrowding, and delayed diagnostics continue to challenge both clinicians and patients in already stretched emergency departments. In this landscape, a robust emergency department EHR is not a luxury but a necessity. CellmaEHR is designed to support the NHS in delivering urgent and emergency care that is faster, safer, and more coordinated. Aligned with the NHS Long Term Plan and the NHS 10-Year Plan, Cellma provides hospitals with a future-ready digital infrastructure that strengthens clinical decision-making, supports patient flow, and improves outcomes while reducing waiting times. Integrations and Standards in the NHS Cellma is designed to link with NHS digital frameworks using connected care across the health ecosystem. Our emergency department EHR complies with and integrates the following: GP Connect – access to GP patient histories – quicker patient history = safer decisions. Shared Care Records – safe, and assured, continuity of care across primary, secondary, and community care connections. Care Identity Service 2 (CIS2) – secure ID mechanism for NHS staff. Personal Demographics Service (PDS) – fast, and accurate, identification of patients. FHIR and HL7 – interoperability with your NHS Systems and third-party platforms. Electronic Prescription Service (EPS) – with prescribing and dispensing directly from A&E. NHS Spine Services – real-time data processing across the national infrastructure. Summary Care Records (SCR) – access to essential patient information for clinicians they need for care such as medications, allergies, and allergies. NHS Federated Data Platform (FDP) – support local data-informed system and hospital flow. NHS e-Referral Service (e-RS) – rapid referral onward to specialist and community services. MESH (Message Exchange for Social Care and Health) – secure data sharing between organisations Cyber Essentials Plus accreditation – indicating a commitment to providing NHS-grade cybersecurity Advanced Reporting & Analytics – Cellma provides real-time reporting dashboards tailored for A&E, including: – 4-hour target compliance reports – Ambulance handover delays – Patient flow and bed occupancy – Triage-to-treatment time tracking – Sepsis and stroke pathway adherence – Re-attendance and discharge summaries These integrations create assurances of clinical robustness, but also digital confidence for hospitals, enabling them to respond to current pressures whilst gearing up for the NHS of tomorrow. Urgent Care Scenarios and Cellma’s Support Urgent Care Scenario How Cellma’s Emergency Department EHR Supports Care Heart Failure BNP/troponin ordering via Lab module, chest X-ray access, red flag alerts for acute decompensation, referral to cardiology and bed management tools. Stroke Direct CT brain request, pathway alerts for thrombolysis/thrombectomy, and rapid neurology referral. STEMI (Heart Attack) Instant ECG upload, troponin tracking, Cath Lab team activation, and cardiology admission coordination. Sepsis Automated sepsis screening, Sepsis 6 protocol embedded, antibiotic prescribing via E-Pharmacy, IV fluid reminders. Major Trauma ATLS protocols within EPR, trauma team activation, real-time coordination with Major Trauma Centres. Asthma/COPD Exacerbation Alerts at triage, protocols for nebulisers/oxygen therapy, vitals monitoring, community respiratory team referrals. Mental Health Crisis Liaison psychiatry referral via Cellma Connect, risk assessment tools (self-harm/suicide risk) safeguarding alerts, coordination with crisis hubs/community care. Paediatric Emergencies Child-specific triage scoring, safeguarding triggers, embedded paediatric protocols for sepsis, asthma, and convulsions. Diabetic Emergencies (DKA/HHS/Hypoglycaemia) Automated glucose/ketone alerts, insulin therapy pathways, fluid balance monitoring, discharge education resources. Managing Complexity in Emergency Care Situations in emergency departments are unique as they are inherently complex as staff manage individuals presenting a range of urgent concerns, from cardiac emergencies, respiratory conditions, neurological issues, sepsis, trauma, and metabolic responses, to name a few. Every single patient in the emergency department needs staff to act quickly, assess skilfully, and collaborate with their colleagues. Cellma, an emergency department EHR provides physicians with access to useful digital tools to support the management of these complex situations: Triage Integration: Automatic notifications when alerts are identified, set up for exploring potential delays in action based on high-risk symptoms, such as chest pain, if stroke/travel signs, sepsis red flags, abnormal vital signs. Lab Management Module: Rapid ordering and tracking of the required diagnostics and their results (cardiac markers, ABG, glucose, infection markers) with results feeding directly into the EPR. Clinical Decision Support: Clinical pathways, care pathways embedded to manage sepsis, STEMI, stroke, DKA, COPD exacerbations, trauma and mental health crisis – receive automatic alerts for abnormal results easy access to support action as specified in nationally agreed guidelines. Integration of Imaging & Diagnostics: Instant referencing of X-rays, CTs, MRIs, ultrasounds, and ECG results for minimal diagnostic delay. Integration of Communication Tools: Referrals for cardiologist, neurologist, orthopaedic, psychiatrist and community services, to provide improved patient coordination. Integration of Patient Education & Discharge Planning: Fully integrated digital education and discharge summaries are sent direct to patients and GPs to assist in reducing re-attendance. Cellma’s Security and Data Privacy Patient data protection is a priority in a fast-paced emergency department. Cellma’s ED EHR provides NHS-grade security systems that maintain: Role-based access controls allow clinical staff to only see relevant patient data. Comprehensive audit trails for accountability and compliance. Data that is encrypted at rest and in transit, ensuring confidentiality. GDPR standard compliance, NHS Digital compliance, Cyber Essentials Plus approved, DSP toolkit compliant, ISO 27001 certified. With all this in place, Cellma ensures that, sensitive patient data remains secure, while allowing clinicians immediate access to the information they require for patient care. The demands of urgent and emergency care continue to grow, but with the right digital infrastructure, clinicians can deliver safer and more effective care. CellmaEHR, an emergency department EHR not only enables timely decision making and efficient patient flow but also ensures full compliance as well as a future-proof approach for the NHS. Book a Free Demo Recent Blogs Let’s transform healthcare together. Speak with RioMed for a tailored solution. Get in Touch FAQs
Hyperlipidemia Symptoms, Diagnosis, and Management
Table of Contents Help Others Discover – Click to Share! Facebook Twitter LinkedIn Table of Contents Hyperlipidemia, commonly referred to as high cholesterol, is one of the top risk factors globally contributing to cardiovascular disease, and it develops relatively silently without warning. Many patients remain unaware of hyperlipidemia symptoms until serious complications like heart attack or stroke occur, making it a silent but dangerous condition. With digital health tools like Cellmaflex, staying ahead of hyperlipidemia has never been easier. From booking online appointments without the hassle of phone calls to reviewing your medical history anytime, anywhere, Cellmaflex helps individuals take a proactive role in managing their health. Patients can use Cellmaflex to also easily discover local doctors, pharmacies, laboratories, and imaging services to ensure comprehensive access to care when needed most. In this blog, we will explore hyperlipidemia in detail – what is it, causes and risk factors, symptoms of hyperlipidemia, potential complications, diagnosis, options for treatment, and lifestyle factors used for long-term management. We will also look at how Cellmaflex helps patients in their care journey. What Is Hyperlipidemia? Hyperlipidemia refers to the presence of excessive fat (lipids) in your blood. This fat is primarily cholesterol and triglycerides (a type of fat and the most common form of fat in the body). While your body needs some cholesterol and fat to make cells and hormones, too much cholesterol and fat in your blood is not healthy. When excess fats stay in your bloodstream, they can attach to the walls of your arteries. Ultimately, fat gets processed into plaques. Plaques narrow arteries and decrease blood flow; therefore, increasing the risk of complications, heart disease, heart attack, or stroke. Globally, high low-density lipoprotein (LDL) cholesterol contributed to significant health burdens in 2019, causing 4.4 million deaths and 98.6 million disability-adjusted life years (DALYs). Prevalence of Hyperlipidemia in the Caribbean Region/Country Age Group Prevalence (%) of Hyperlipidemia Jamaica Adults (15–74) 11.7% with high total cholesterol Barbados Adults 21% with elevated total cholesterol Trinidad & Tobago (national survey) Adults (≥40 years) 21.2% self-reported hypercholesterolemia Trinidad & Tobago (North vs South) Adults (regional) 27% in North, 52% in South with dyslipidemia Plaque can occur and cause: Narrowing of arteries (stenosis) – limiting the tissue’s ability to get oxygen. Ruptured plaque – exposing thrombogenic contents, blood clot formation, and acute events, like myocardial infarction or stroke. The World Health Organisation (WHO) estimates raised cholesterol will cause 2.6 million deaths worldwide each year. This highlights why early identification, even if no symptoms of hyperlipidemia are present, is important. Types of Cholesterol Not all cholesterol is created equal. Understanding the different types helps explain why managing cholesterol levels is so important. LDL (“bad” cholesterol): This cholesterol tends to deposit in artery walls, creating plaques that narrows blood vessels and reduces blood flow. HDL (“good” cholesterol): Unlike LDL, HDL removes excess cholesterol from your blood and carries it back to the liver where it is broken down and removed from the body. Triglycerides: These are fats derived from the calories your body doesn’t use immediately. High triglycerides are strongly linked to cardiovascular disease risk. With Cellmaflex, you can book a lipid panel test at nearby labs and keep your results stored in your digital medical records for easy access anytime, anywhere. Causes & Risk Factors Hyperlipidemia can be either primary (genetic) or secondary (diet or disease related). Primary (Genetic Disorders) Familial Hypercholesterolemia (FH) – This disorder is caused by mutations in the LDL receptor genes so that the individual has very high levels of LDL beginning at birth. Without treatment, these individuals have an extremely high risk for early myocardial infarction (heart attack). Familial Combined Hyperlipidemia -An inherited condition characterised by elevated levels of both cholesterol and triglycerides, significantly increasing the risk of early heart disease. Secondary Causes Diet – Diet can lead to elevations of lipids, especially with an increase in saturated fats, trans fats, and refined carbohydrates. Lifestyle – A sedentary lifestyle will lower HDL and elevate cholesterol levels. Medical Conditions: Diabetes mellitus, hypothyroidism, chronic kidney disease, liver disease, and nephrotic syndrome. With Cellmaflex, medical history including comorbidities and medications can be stored and accessed in one place, allowing doctors to better assess whether hyperlipidemia is primary or secondary. Hyperlipidemia Symptoms Here lies the challenge: hyperlipidemia symptoms are often absent until vascular disease has advanced. This is why it’s frequently described as a “silent killer.” In rare cases, visible clinical signs may occur: Xanthomas: Yellowish deposits of cholesterol-rich material under the skin, often on tendons or eyelids. Corneal arcus: A white or grey ring around the cornea. In younger patients under 40, this is referred to as arcus juvenilis and often suggests a genetic lipid disorder such as familial hypercholesterolemia. In older individuals, typically aged 50–60 years or more, it is called arcus senilis and is generally considered an age-related change. Hyperlipidaemia can cause xanthomas, which are fatty deposits in the skin or tendons. Most types are linked to high cholesterol, while eruptive xanthomas are usually due to very high triglycerides but may also occur with raised cholesterol. Hyperlipidemia symptoms may present as angina, shortness of breath, or fatigue during exercise and are somewhat clinical and typically related to narrowing of coronary arteries. By the time these symptoms develop, the arterial disease is often quite significant. This makes preventive lipid screening crucial. Cellmaflex helps patients book lipid screening at their nearby labs. Complications If hyperlipidemia remains untreated, the following potentially fatal conditions can occur: Coronary Artery Disease (CAD): Narrowed arteries that reduce perfusion to the myocardium, leading to myocardial infarction. Cerebrovascular Disease: Increased risk of ischemic stroke due to embolism or rupture of a plaque. Peripheral Artery Disease (PAD): Claudication (a type of muscle pain or cramping, most often in the legs, that is triggered by physical activity and relieved by rest), non-healing wounds, and/or limb ischemia as a result of narrowed arteries. Hypertension: Resulting from stiffened, narrowed arteries that increase vascular resistance. Chronic Kidney Disease (CKD): A reduction in the perfusion of renal
Choose Physiotherapy Software Easily with Cellma
Table of Contents Help Others Discover – Click to Share! Facebook Twitter LinkedIn Table of Contents Physiotherapy has an ever-expanding footprint in primary care throughout the UK. In fact, according to NHS surveys, 86.4% of musculoskeletal patients were managed in primary care, with only 8.5% in outpatient physiotherapy and 5.1% in orthopaedics. The First Contact Physiotherapy (FCP) model has played a key role in this by enabling patients to see a musculoskeletal physiotherapist directly without having to see a GP first. Yet, despite advances made, it remains a challenge when faced with long waiting times. In some areas, patients still face 12–26 weeks before accessing care which invariably affects their recovery and subsequently can lead to poorer long-term outcomes. This is exactly why digital innovation is no longer optional. Clinics need a system that reduces delays, connects care teams, and ensures patients are supported at every stage. And when it comes to making the decision to choose physiotherapy software, the solution is clear: CellmaEHR. It is built to manage the complete physiotherapy journey, referral, triage, assessment, treatment, reporting, and recovery, within one secure and NHS-compliant platform. NHS Compliant and Future-Proof When clinics choose physiotherapy software, compliance with NHS guidelines is non-negotiable. CellmaEHR ticks every box, fully aligned with the NHS Long Term Plan to deliver digital-first, connected, and fit-for-future healthcare services. This ensures that physiotherapy clinics can confidently meet today’s compliance standards while being prepared for tomorrow’s evolving care models. CellmaEHR delivers on this with: NHS Coding Libraries – SNOMED CT, ICD-10, OPCS-4 Mandatory Submissions – CSDS, FFT, PROMs, evidence for CQC/Governance Standards – Interoperable with GP Connect, FHIR, HL7, Shared Care Records Accessibility – DTAC approved, WCAG 2.1/2.2 AA compliant Quality, Privacy and Security – GDPR, DSPT, DCB standards, Cyber Essentials Plus This ensures that every referral, assessment, and care plan in physiotherapy is securely recorded, instantly shareable across NHS systems, and ready for reporting without extra admin. Supporting the NHS First Contact Physiotherapy (FCP) Model The First Contact Physiotherapy (FCP) model, supported by the NHS and detailed in reports from NHS England, allows patients with musculoskeletal (MSK) conditions to directly access highly trained physiotherapists in GP practices, without needing a GP referral. These reports highlight that FCP improves patient outcomes, reduces GP workload, and shortens waiting times for care. The NHS has highlighted in its report on the First Contact Physiotherapy (FCP) model that giving patients direct access to musculoskeletal physiotherapists in primary care reduces GP workload and enables quicker treatment. However, the report also notes key challenges such as long waiting times, regional variations in access, and inconsistent outcome reporting. CellmaEHR is designed to address these priorities head-on: Patient Portal with self-referral and triage tools to cut waiting times and manage demand. Built-in outcome measurement templates (PROMs, pain scores, mobility assessments) for consistent and standardised reporting. Interoperability with NHS systems (GP Connect, Shared Care Records, FHIR, HL7) for seamless continuity of care. Automated reporting for CSDS, FFT, PROMs, and CQC evidence, reducing administrative burdens highlighted in the NHS report. By supporting the FCP model, Cellma helps physiotherapy providers stay fully compliant while aligning with the NHS Long Term Plan’s vision for faster access, reduced system pressure, and digital-first care. Clinical Model: Conditions Treated in Physiotherapy Physiotherapy encompasses vast range of conditions along the continuum of musculoskeletal, neurological, or rehabilitation post-surgical conditions. Whether it be back pain, osteoarthritis, sports injuries, stroke rehabilitation, or post joint replacement conditions, physiotherapy requires comprehensive assessments, individualised care plans, and continued clinical assessments. When clinics implement physiotherapy software such as CellmaEHR, physiotherapists have access to condition-based templates, outcome scales, track validated outcome measures to show clinical audit and evidence-based care and patient engagement tools. For instance: Back and Neck Pain – CellmaEHR records a pain scale and functional scores and develops progressive care plans. Arthritis & Joint Disorders – assessing and monitoring mobility and pain regularly over the same timeframe digitally. Neurological Conditions – Templates for the assessment and rehab of stroke, MS, and Parkinson’s ensures the therapy process is organized. Post-Surgical Rehab – Shared care plans through the referral portal for orthopaedics and physiotherapy teams. Chronic Pain & Complex Cases – Greater co-ordination between the multi-disciplinary team indexes the complexities via shared records and care pathways. By offering a seamless pathway for physiotherapy care, from referral stage and follow-up care, CellmaEHR enables clinicians to shift their focus away from paper-based processes and focus on results for clients. CellmaEHR Features for Physiotherapy Clinics When selecting physiotherapy software, you require more than a scheduling piece of software. CellmaEHR is an EMR complete platform which manages real world issues such as waiting time, duplication of records, timeliness of reporting, etc. Patient Administration System (PAS): Efficient referral logging, triage, and appointment scheduling. Electronic Patient Record (EPR): Structured templates for assessments, scoring, and progress tracking. Care Plan Management: Create and share personalised rehab plans, including hybrid models for in-clinic and remote care. Patient Portal: Allows patients to submit self-referrals, access their care plans, view progress notes, and receive educational materials. By empowering patients to engage with their treatment directly, the portal helps reduce appointment backlogs and keeps patients informed throughout their recovery. Referral Portal: Smoother connection to GPs, orthopaedics and community teams to ensure continuity of care. Document & Imaging Integrations: Access reports, XRays, and MRIs in the same platform. Lab Management & E-Pharmacy: Support integrated diagnostics and treatments where applicable. Business Intelligence (BI) Reporting: PROMs, activity analysis, and NHS submissions – all automated. Multidisciplinary Team (MDT) Collaboration: Enables coordinated input from physiotherapists, orthopaedic specialists, occupational therapists, and other healthcare professionals in one shared record, ensuring holistic patient care. Addressing excessive wait time- which is a large issue presently in UK Physiotherapy- is addressed with self-referral portals, triage structure and reporting completion. In this way, wait times are minimized allowing your staff to give care and not concern themselves with administrative matters. Privacy and Security You Can Trust Privacy and security of data is vital in selecting physiotherapy software. CellmaEHR provides NHS-level reassurance about security in four keyways: Compliant with GDPR in terms of data handling Cyber Essentials